Patents by Inventor Eric Thomas NEWCOMB

Eric Thomas NEWCOMB has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Arginase inhibitors
    Patent number: 12054500
    Abstract: Compounds that are inhibitors of at least one of the ARG1 and ARG2, and compositions containing the compounds and methods for synthesizing the compounds, are described herein. The use of such compounds and compositions for the treatment of a diverse array of diseases, disorders, and conditions, including cancer- and immune-related disorders that are mediated, at least in part, by ARG1 and ARG2 are also described herein.
    Type: Grant
    Filed: March 4, 2019
    Date of Patent: August 6, 2024
    Assignee: Arcus Biosciences, Inc.
    Inventors: Corinne Nicole Foley, Rebecca Louise Grange, Tezcan Guney, Jaroslaw Kalisiak, Eric Thomas Newcomb, Anh Thu Tran
  • INHIBITORS OF ARG1 AND/OR ARG2
    Publication number: 20220016143
    Abstract: Compounds that are inhibitors of at least one of ARG1 and ARG2, and compositions containing the compounds and methods for synthesizing the compounds, are described herein. The use of such compounds and compositions for the treatment of a diverse array of diseases, disorders, and conditions, including cancer- and immune-related disorders that are mediated, at least in part, by ARG1 and ARG2 are also described herein.
    Type: Application
    Filed: November 15, 2019
    Publication date: January 20, 2022
    Inventors: Joel BEATTY, Eric Thomas NEWCOMB, Jay Patrick POWERS, Brandon Reid ROSEN, Yongli SU, Anh Thu TRAN, Corinne Nicole FOLEY, Rebecca Louise GRANGE, Tezcan GUNEY, Steven Donald JACOB, Jaroslaw KALISIAK, Manmohan Reddy LELETI, Erick Allen LINDSEY, Debashis MANDAL
  • ARGINASE INHIBITORS
    Publication number: 20210002306
    Abstract: Compounds that are inhibitors of at least one of the ARG1 and ARG2, and compositions containing the compounds and methods for synthesizing the compounds, are described herein. The use of such compounds and compositions for the treatment of a diverse array of diseases, disorders, and conditions, including cancer- and immune-related disorders that are mediated, at least in part, by ARG1 and ARG2 are also described herein.
    Type: Application
    Filed: March 4, 2019
    Publication date: January 7, 2021
    Inventors: Corinne Nicole FOLEY, Rebecca Louise GRANGE, Tezcan GUNEY, Jaroslaw KALISIAK, Eric Thomas NEWCOMB, Anh Thu TRAN